收藏切换
Preliminary study on the scientific and technological innovation index of listed Chinese patent medicine enterprises
收藏切换
An-qi JIN1, Fei-lin LI2, Ling QUE2, Meng CHENG1, Guang YANG1, Min CHEN1
Chinese Journal of New Drugs | 2021, 30(18) : 1642 - 1648
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(18): 1642-1648
Preliminary study on the scientific and technological innovation index of listed Chinese patent medicine enterprises
Full
An-qi JIN1, Fei-lin LI2, Ling QUE2, Meng CHENG1, Guang YANG1, Min CHEN1
Affiliations
  • 1National Resource Center for Chinese Materia Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
  • 2School of Economics and Resource Management, Beijing Normal University, Beijing 100875, China
Published: 2021-09-30
Outline
收藏切换

In recent years, the economy of Chinese patent medicine industry has shown a downward trend, manifesting by the detailed problems of small-scaled pharmaceutical companies, low benefits, low achievements, and weak technological development and innovation capabilities. In order to reverse the current situation of inadequate technological innovation of Chinese patent medicines and improve the technological innovation level of Chinese patent medicine enterprises, this article preliminarily explores the construction of a set of scientific and technological innovation index evaluation systems with the Chinese patent medicine enterprises as the main body. Judging from the existing index evaluation status, there has not been any evaluation researches in the field of traditional Chinese medicine. Therefore, this paper takes 21 listed enterprises of Chinese patent medicine as the study object, combines with the “scale-efficiency-structure” index framework to screen out 10 indicators, including R&D funding investment and the number of R&D personnel, uses the entropy method out of objective weighting methods to determine the weight of each indicator, and initially constructs a comprehensive index evaluation method. The results show that during the years of 2015 to 2018, the scientific and technological innovation index of 21 listed Chinese patent medicine companies showed a peak, with the peak value appearing in 2016. This trend is consistent with that of sales revenue and profit of Chinese patent medicine industry in the same period. Compared with the net profit index of the company after deducting non-recurring gains and losses, the result is close to 70% after rank correlation analysis and comparison.

proprietary Chinese medicine listed enterprises  /  scientific and technology innovation index  /  scale-efficiency-structure
金安琪, 李斐琳, 阙灵, 程蒙, 杨光, 陈敏. 中成药上市企业科技创新指数研究初探. 中国新药杂志, 2021 , 30 (18) : 1642 -1648 .
An-qi JIN, Fei-lin LI, Ling QUE, Meng CHENG, Guang YANG, Min CHEN. Preliminary study on the scientific and technological innovation index of listed Chinese patent medicine enterprises[J]. Chinese Journal of New Drugs, 2021 , 30 (18) : 1642 -1648 .
Year 2021 volume 30 Issue 18
24
3
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-30
  • Published:2021-09-30
Article Data
Affiliations
History
  • Accepted:2020-12-10
Affiliations
    1National Resource Center for Chinese Materia Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
    2School of Economics and Resource Management, Beijing Normal University, Beijing 100875, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT